LindsayElizabeth(Mclellan)BordenMD
Obstetrics & Gynecology • Newport News, VAGynecologic Oncology
Physician
Are you Dr. Borden?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 9 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12100 Warwick Blvd Ste 202
Newport News, VA 23601Phone+1 757-594-4198Fax+1 757-594-5142- Is this information wrong?
Summary
- Dr. Lindsay (Mclellan) Borden, MD is an obstetrician/gynecologist in Newport News, Virginia. She is currently licensed to practice medicine in Virginia and Oklahoma. She is affiliated with Oklahoma Children’s Hospital OU Health.
Education & Training
Carilion Clinic-Virginia Tech Carilion School of MedicineResidency, Obstetrics and Gynecology, 2016 - 2020
University of Virginia School of MedicineClass of 2016
Certifications & Licensure
VA State Medical License 2016 - 2024
OK State Medical License 2019 - 2023- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- End-to-end deep learning method for predicting hormonal treatment response in women with atypical endometrial hyperplasia or endometrial cancer.Kahaki, S., Cha, K., Trindade, C., Petrick, N., Chen, W., Hagemann, I., Kostelecky, N., Borden, L., Atwi, D., Fung, K.> ;Journal of Medical Imaging. 2024 Jan 1
- 7 citationsTP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.Karley Whelan, Mairead Dillon, Kyle C Strickland, Bhavana Pothuri, Victoria Bae-Jump, Lindsay E Borden, Premal H Thaker, Paulina Haight, Rebecca C Arend, Emily Ko, Ama...> ;Gynecologic Oncology. 2023 Nov 1
- 3 citationsIdentification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities.Pouya Javadian, Chao Xu, Virginie Sjoelund, Lindsay E Borden, Justin Garland, Doris Mangiaracina Benbrook> ;International Journal of Molecular Sciences. 2022 Jul 14
- Join now to see all
Press Mentions
Findings Support Retesting for MMRD at Uterine Cancer RecurrenceApril 8th, 2022
Hospital Affiliations
Oklahoma Children’s Hospital OU HealthOklahoma City, Oklahoma
